Eiken Chemical Co (TSE:4549) Piotroski F-Score: 7 (As of Jun. 28, 2026) — 17% Above Median


TSE:4549 Eiken Chemical Co Ltd TSE:4549
81 GF Score
Price 円2,525.00
GF Value 円2,477.93
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Eiken Chemical Co Piotroski F-Score?

Eiken Chemical Co TSE:4549 +1.45% 81 Piotroski F-Score is 7 as of Jun. 28, 2026, which is 17% above its 10-year median of 6.00. GuruFocus rates TSE:4549 with a GF Score™ of 81/100 and a GF Value™ of 円2,477.93 (Fairly Valued). The stock has 4 warning signs investors should review. Among 807 Medical Devices & Instruments companies, Eiken Chemical Co ranks better than 92.44% on this metric.

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Eiken Chemical Co has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Eiken Chemical Co's Piotroski F-Score or its related term are showing as below:

TSE:4549' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 6   Max: 7
Current: 7

During the past 13 years, the highest Piotroski F-Score of Eiken Chemical Co was 7. The lowest was 4. And the median was 6.

Eiken Chemical Co  (TSE:4549) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Eiken Chemical Co Piotroski F-Score Related Terms


Eiken Chemical Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Eiken Chemical Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eiken Chemical Co Piotroski F-Score Chart

Eiken Chemical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 5.00 5.00 5.00 7.00

Eiken Chemical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 0.00 0.00 0.00 7.00

TSE:4549 vs ABT, SYK, MDT: Piotroski F-Score Comparison

For the Medical Devices subindustry, Eiken Chemical Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eiken Chemical Co Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eiken Chemical Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Eiken Chemical Co's Piotroski F-Score falls into.


TSE:4549
81GF Score
Eiken Chemical Co Ltd TSE:4549
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 円3,708 Mil.
Cash Flow from Operations was 円4,045 Mil.
Revenue was 円41,899 Mil.
Gross Profit was 円16,175 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was (62372 + 62657) / 2 = 円62514.5 Mil.
Total Assets at the begining of this year (Mar25) was 円62,372 Mil.
Long-Term Debt & Capital Lease Obligation was 円3,580 Mil.
Total Current Assets was 円32,040 Mil.
Total Current Liabilities was 円14,636 Mil.
Net Income was 円2,228 Mil.

Revenue was 円40,539 Mil.
Gross Profit was 円16,512 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was (61651 + 62372) / 2 = 円62011.5 Mil.
Total Assets at the begining of last year (Mar24) was 円61,651 Mil.
Long-Term Debt & Capital Lease Obligation was 円4,038 Mil.
Total Current Assets was 円31,532 Mil.
Total Current Liabilities was 円14,376 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Eiken Chemical Co's current Net Income (TTM) was 3,708. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Eiken Chemical Co's current Cash Flow from Operations (TTM) was 4,045. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=3708/62372
=0.05944975

ROA (Last Year)=Net Income/Total Assets (Mar24)
=2228/61651
=0.03613891

Eiken Chemical Co's return on assets of this year was 0.05944975. Eiken Chemical Co's return on assets of last year was 0.03613891. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Eiken Chemical Co's current Net Income (TTM) was 3,708. Eiken Chemical Co's current Cash Flow from Operations (TTM) was 4,045. ==> 4,045 > 3,708 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=3580/62514.5
=0.05726671

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=4038/62011.5
=0.06511695

Eiken Chemical Co's gearing of this year was 0.05726671. Eiken Chemical Co's gearing of last year was 0.06511695. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=32040/14636
=2.18912271

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=31532/14376
=2.19337785

Eiken Chemical Co's current ratio of this year was 2.18912271. Eiken Chemical Co's current ratio of last year was 2.19337785. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Eiken Chemical Co's number of shares in issue this year was 33.084. Eiken Chemical Co's number of shares in issue last year was 34.666. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=16175/41899
=0.3860474

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=16512/40539
=0.40731148

Eiken Chemical Co's gross margin of this year was 0.3860474. Eiken Chemical Co's gross margin of last year was 0.40731148. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=41899/62372
=0.67175976

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=40539/61651
=0.65755624

Eiken Chemical Co's asset turnover of this year was 0.67175976. Eiken Chemical Co's asset turnover of last year was 0.65755624. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+0+1+0+1
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Eiken Chemical Co has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 7 mean?
Eiken Chemical Co (TSE:4549) has a Piotroski F-Score of 7 as of Jun. 28, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Eiken Chemical Co and its competitors. This is 17% above median its historical median of 6.00. Over the past decade, Eiken Chemical Co's Piotroski F-Score has ranged from 4.00 to 7.00. According to the industry distribution chart, Eiken Chemical Co ranks #61 out of 807 companies in the Medical Devices & Instruments industry, placing it in the top 7.6%.
Is Eiken Chemical Co's Piotroski F-Score too high?
Eiken Chemical Co's current Piotroski F-Score of 7 is 17% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 7.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Eiken Chemical Co's value of 7 is 40% above this industry median. Based on the distribution chart, Eiken Chemical Co ranks #61 out of 807 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Eiken Chemical Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eiken Chemical Co's Piotroski F-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Eiken Chemical Co ranks #61 out of 807 companies for Piotroski F-Score. This places Eiken Chemical Co in the top 8% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Eiken Chemical Co's value of 7 is 40% above this benchmark. Historically, Eiken Chemical Co's own Piotroski F-Score has ranged from 4.00 to 7.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Eiken Chemical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 807 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eiken Chemical Co's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Eiken Chemical Co and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eiken Chemical Co's current Piotroski F-Score is 7, which is 17% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eiken Chemical Co stock overvalued right now?
Based on GuruFocus' analysis, Eiken Chemical Co (TSE:4549) is currently considered Fairly Valued. The stock's GF Value™ is 円2,477.93, compared to a current price of 円2,525.00 — trading 1.9% above its estimated fair value. The current Piotroski F-Score is 7, which is 17% above median its 10-year median of 6.00 and 40% above the Medical Devices & Instruments industry median of 5.00. Eiken Chemical Co's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Eiken Chemical Co (TSE:4549), the current Piotroski F-Score is 7 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eiken Chemical Co (TSE:4549) Overvalued in 2026?

Based on GuruFocus' analysis, Eiken Chemical Co stock appears to be overvalued. The current stock price of 円2,525.00 is trading 1.9% above its estimated GF Value™ of 円2,477.93. GuruFocus considers Eiken Chemical Co to be Fairly Valued.

Key valuation signals for TSE:4549:

  • Piotroski F-Score: 7 (17% above median its 10-year median of 6.00)
  • GF Value™: 円2,477.93 vs. price of 円2,525.00 (1.9% above fair value)
  • GF Score™: 81/100 with 4 warning signs
  • Industry Position: 40% above the Medical Devices & Instruments median (#61 of 807)

No single metric tells the full story. See the TSE:4549 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eiken Chemical Co Business Description

Address 4-19-9 Taito, Taito-ku, Tokyo, JPN, 110-8408
Eiken Chemical Co Ltd is a Japan-based company. It manufactures and sells clinical diagnostics and equipment. The company is engaged in processing, manufacture, purchase and sale of test agents, property and casualty insurance agency business. It as a general manufacturer of clinical diagnostics offers a wide range of in vitro diagnostic aids for all fields of medicine. Its major products include the Fecal immunochemical test, Molecular Genetics (LAMP), Microbiology, among many others.
81GF Score

Get the complete analysis for TSE:4549

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,525.00
Price
円2,477.93
GF Value